More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$17.81B
P/E ratio
24.9
Dividend yield
1.6366%
Expense ratio
0.09%
Beta
0.600141
Previous close
$299.80
Today's open
$300.21
Day's range
$299.71 - $303.68
52 week range
$237.23 - $311.67
Industries
Health
As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026?
Vanguard Health Care ETF offers a lower expense ratio and higher dividend yield than Invesco Pharmaceuticals ETF Invesco Pharmaceuticals ETF has concentrated its portfolio in 29 pharmaceutical stocks whereas Vanguard Health Care ETF holds 411 healthcare companies Invesco Pharmaceuticals ETF significantly outperformed on a 1-year total return basis
The Motley Fool • Jul 22, 2026

Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?
Vanguard Health Care ETF offers a significantly lower expense ratio of 0.09% compared to 0.38% for iShares U.S. Pharmaceuticals ETF iShares U.S. Pharmaceuticals ETF has delivered higher total returns over the last five years but carries higher concentration risk with only 56 holdings Vanguard Health Care ETF provides broader sector diversification by covering the entire medical ecosystem while the iShares fund focuses strictly on drug manufacturers
The Motley Fool • Jul 22, 2026

Use These ETFs as Health Stocks LLY, UNH, MRK Thrive
Health stocks had a strong week, with some big firms seeing drugs approved. Eli Lilly (LLY) reportedly neared an agreement to acquire a psychedelics company.
ETF Trends • Jul 17, 2026

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.
Zacks Investment Research • Jul 14, 2026

How to Play Fresh U.S.-Iran Tensions With ETFs?
Market jitters return on fresh U.S.-Iran tensions. Energy, dividend, low-volatility and defensive ETFs could help investors navigate renewed uncertainty.
Zacks Investment Research • Jul 9, 2026

Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and higher dosing—effectively extends product lifecycles and drives shareholder value.
Seeking Alpha • Jun 29, 2026

Should You Invest in the Vanguard Health Care Index Fund ETF Shares (VHT)?
The Vanguard Health Care Index Fund ETF Shares (VHT) was launched on January 26, 2004, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.
Zacks Investment Research • Jun 18, 2026

Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy?
The Vanguard Health Care ETF offers a significantly lower expense ratio than the VanEck Pharmaceutical ETF. The VanEck Pharmaceutical ETF has a higher concentration and higher trailing returns, while the Vanguard Health Care ETF provides broader sector diversification across more than 400 holdings.
The Motley Fool • Jun 18, 2026

Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
Healthcare ETFs are gaining attention as Middle East tensions and market volatility boost demand for defensive sectors.
Zacks Investment Research • Jun 9, 2026

Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet
LLY's $4B vaccine push is boosting interest in healthcare ETFs like IHE with heavy exposure to the drugmaker.
Zacks Investment Research • May 29, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Vanguard Health Care ETF commission-free¹. Build wealth for the long term using automated trading and transfers.